PDLI R&D Expense Growth
Pdl Biopharma Inc · R&D Expense Growth
PDLI R&D Expense Growth
Latest reported147.31%period ending
PDLI FY R&D Growth (YoY) (0.00% → 147.31%)
Latest values, visible window
High-resolution chart · PNG
PDLI r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 147.3096% | |
| -59.9648% | |
| 93.2199% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| -21.67% | |
| 51.5122% | |
| 40.3678% | |
| 48.1446% | |
| 42.6955% | |
| 11.1264% | |
| 23.2414% | |
| 17.2687% | |
| 14.2405% | |
| 23.4375% | |
| -11.1111% | |
| 0% |